Mr. Bier is a communications and strategy expert who has played a key role in building brands
VANCOUVER, BC, Oct. 8, 2020 /CNW/ - Mind Cure Health Inc. (CSE: MCUR)
("Mind Cure" or the "Corporation") is pleased to announce today the addition of Jon Bier to the company's advisory board. Mr. Bier, the founder of Jack Taylor PR and an adjunct marketing professor at New York University, is known for his work with some of the world's leading health and wellness brands.
With his role on Mind Cure's advisory board, Mr. Bier will be tasked with helping to bring Mind Cure's mission to life. He understands how to share the story of functional medicine and psychedelics and is intimately connected within the health and wellness space.
"I am deeply passionate about the mission of Mind Cure," said Jon Bier. "I believe in the power and potential of the psychedelics movement to cure mental illness, backed by science and research. I focus my work exclusively on companies and brands that are helping people to live better lives, and I look forward to helping Mind Cure tell its story and build an iconic brand with integrity."
"Our industry needs people like Jon to tell the story of the revolution in mental health care, the value of nootropic products and the momentum in psychedelic research in the right way," stated Philip Tapley, Mind Cure Chairman, President, and CEO. "We are committed to building Mind Cure the right way, and Jon will help us to share this message of trust and integrity with the market and connect with our future customers."
About Jon Bier
Jon Bier is a 15+ year marketing and public relations veteran and CEO/Founder of Jack Taylor PR, a communications agency with offices in Brooklyn, NY and Venice, CA. He is a bar-admitted non-practicing attorney and Adjunct Professor of Marketing at New York University. Jon is known as is an expert storyteller and brand builder, having worked with health and wellness industry leaders.
About Mind Cure Health Inc.
Mind Cure is a mental health and wellness company with a mission to identify, develop and commercialize products that ease suffering, increase productivity, and enhance mental health. It is the therapeutic potential of nootropics, psychoactive products, and psychedelic substances to treat the profound distress of a world suffering from a mental health crisis that led to the formation of Mind Cure.
On Behalf of the Board of Directors
Philip Tapley, Chairman, President, and CEO
Certain statements in this news release may constitute "forward-looking information" within the meaning of applicable securities laws (also known as forward-looking statements). Forward- looking information involves known and unknown risks, uncertainties and other factors, and may cause actual results, performance or achievements or industry results, to be materially different from any future results, performance or achievements or industry results expressed or implied by such forward-looking information. Forward-looking information generally can be identified by the use of terms and phrases such as "anticipate", "believe", "could", "estimate", "expect", "feel", "intend", "may", "plan", "predict", "project", "subject to", "will", "would", and similar terms and phrases, including references to assumptions. Some of the specific forward-looking information in this news release includes, but is not limited to, statements with respect to: Mr. Bier being tasked with helping to bring Mind Cure's mission to life; the belief in the power and potential of the psychedelics movement to cure mental illness; Mr. Bier telling Mind Cure's story and building an iconic brand; and Mr. Bier sharing Mind Cure's message of trust and integrity with the market and connect with its future customers.
Forward-looking information is based on a number of key expectations and assumptions made by Mind Cure, including, without limitation: the COVID-19 pandemic impact on the Canadian economy and Mind Cure's business, and the extent and duration of such impact; no change to laws or regulations that negatively affect Mind Cure's business; there will be a demand for Mind Cure's products in the future; Mind Cure will be able to continue to identify products that make them ideal candidates for providing solutions for treating mental health; the addition of Mr. Bier will help Mind Cure bring its mission to life and share other messages of Mind Cure; and Mind Cure will be able to operate its business as planned. Although the forward-looking information contained in this news release is based upon what Mind Cure believes to be reasonable assumptions, it cannot assure investors that actual results will be consistent with such information.
Forward-looking information is provided for the purpose of presenting information about management's current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. Forward-looking information involves significant risks and uncertainties and should not be read as a guarantee of future performance or results as actual results may differ materially from those expressed or implied in such forward-looking information. Those risks and uncertainties include, among other things, risks related to: the impacts of the COVID-19 pandemic on the Canadian economy, Mind Cure's industry and Mind Cure's business, which may negatively impact, and may continue to negatively impact, Mind Cure and may materially adversely affect Mind Cure's investments, results of operations, financial condition and Mind Cure's ability to obtain additional equity or debt financing, and satisfy its financial obligations; general economic conditions; future growth potential; competition for mental health and wellness investments; the addition of Mr. Bier may not help Mind Cure bring its mission to life and share other messages of Mind Cure; and changes in legislation or regulations. Management believes that the expectations reflected in the forward-looking information contained herein are based upon reasonable assumptions and information currently available; however, management can give no assurance that actual results will be consistent with such forward-looking information. Additional information on the risk factors that could affect Mind Cure can be found under "Risk Factors" in Mind Cure's final prospectus which is available on SEDAR at www.sedar.com.
The forward-looking information contained herein is expressly qualified in its entirety by this cautionary statement. Forward-looking information reflects management's current beliefs and is based on information currently available to Mind Cure. The forward-looking information is stated as of the date of this news release and Mind Cure assumes no obligation to update or revise such information to reflect new events or circumstances, except as may be required by applicable law.
The CSE has neither approved nor disapproved the contents of this press release and the CSE does not accept responsibility for the adequacy or accuracy of this release.
SOURCE Mind Cure Health Inc.
For further information: Investor Relations: firstname.lastname@example.org; 1-888-593-8995
Original source: https://www.newswire.ca/news-releases/health-and-wellness-industry-tastemaker-jon-bier-joins-mind-cure-s-advisory-board-853666120.html
Please see full disclaimers at PsychedelicStockWatch.com applicable to all content provided by PSW, wherever published or republished: https://psychedelicstockwatch.com/statements-policies
This news release/advertorial is a commercial advertisement and is for general information purposes only. The information provided by PSW through this website or other means does not constitute an offer or solicitation to buy or sell any securities or individualized investment advice. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in small-cap and micro-cap securities is highly speculative and carries an extremely high degree of risk. This website makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Psychedelic Stock Watch and/or entities related to Psychedelic Stock Watch may or may not hold shares in (CSE: MCUR) and may or may not intend to sell those shares. Please review all investment decisions with a licensed investment advisor.